{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:27:06Z","timestamp":1783042026639,"version":"3.54.6"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.bone.2013.02.004","type":"journal-article","created":{"date-parts":[[2013,2,16]],"date-time":"2013-02-16T04:16:04Z","timestamp":1360988164000},"page":"495-500","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":116,"title":["Proposed pathogenesis for atypical femoral fractures: Lessons from materials research"],"prefix":"10.1016","volume":"55","author":[{"given":"B.","family":"Ettinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.B.","family":"Burr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.O.","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2013.02.004_bb0005","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/jbmr.253","article-title":"American Society for Bone and Mineral Research. Atypical subtrochanteric and diaphyseal femoral: report of a task force of the American Society for Bone and Mineral Research","volume":"25","author":"Shane","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.02.004_bb0010","first-page":"77","article-title":"Distribution of atypical fractures and cortical stress lesions in the femur: implications on pathophysiology","volume":"52","author":"Koh","year":"2011","journal-title":"Singapore Med J"},{"key":"10.1016\/j.bone.2013.02.004_bb0015","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/jbmr.543","article-title":"Evolution of bisphosphonate-related atypical fracture retrospectively observed with DXA scanning","volume":"27","author":"Ahlman","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.02.004_bb0020","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00330-012-2587-y","article-title":"Radiographic features of multifocal endosteal thickening of the femur in patients on long-term bisphosphonate therapy","volume":"23","author":"Mohan","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1016\/j.bone.2013.02.004_bb0025","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.matbio.2007.07.006","article-title":"In situ examination of the time-course for secondary mineralization of Haversian bone using synchrotron Fourier transform infrared microspectroscopy","volume":"27","author":"Fuchs","year":"2008","journal-title":"Matrix Biol"},{"key":"10.1016\/j.bone.2013.02.004_bb0030","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1185\/030079903125003125","article-title":"Efficacy of risedronate on clinical vertebral fractures within six months","volume":"20","author":"Roux","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.bone.2013.02.004_bb0035","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00223-003-0042-4","article-title":"Risedronate rapidly reduces risk for non-vertebral fractures in women with postmenopausal osteoporosis","volume":"74","author":"Harrington","year":"2004","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.bone.2013.02.004_bb0040","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3949\/ccjm.78a.11022","article-title":"What is the optimal duration of bisphosphonate therapy?","volume":"78","author":"Ott","year":"2011","journal-title":"Cleve Clin"},{"key":"10.1016\/j.bone.2013.02.004_bb0045","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0169-6009(90)90061-J","article-title":"A comparison of iliac bone histomorphometric data in post-menopausal osteoporotic and normal subjects","volume":"11","author":"Kimmel","year":"1990","journal-title":"Bone Miner"},{"key":"10.1016\/j.bone.2013.02.004_bb0050","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1172\/JCI119668","article-title":"Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis","volume":"100","author":"Chavassieux","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2013.02.004_bb0055","first-page":"720","article-title":"Alendronate and estrogen effects in postmenopausal women with low bone mineral density","volume":"85","author":"Bone","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2013.02.004_bb0060","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","article-title":"Severely suppressed bone turnover: a potential complication of alendronate therapy","volume":"90","author":"Odvina","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2013.02.004_bb0065","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1359\/jbmr.070609","article-title":"Microcrack frequency and bone remodeling in postmenopausal women on long-term bisphosphonates: a bone biopsy study","volume":"22","author":"Chapurlat","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.02.004_bb0070","doi-asserted-by":"crossref","first-page":"14416","DOI":"10.1073\/pnas.1107966108","article-title":"Age-related changes in the plasticity and toughness of human cortical bone at multiple length scales","volume":"108","author":"Zimmerman","year":"2011","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bone.2013.02.004_bb0075","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nmat832","article-title":"Mechanistic fracture criteria for the failure of human cortical bone","volume":"2","author":"Nalla","year":"2003","journal-title":"Nat Mater"},{"key":"10.1016\/j.bone.2013.02.004_bb0080","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.jbiomech.2008.02.017","article-title":"Failure of mineralized collagen fibrils: modeling the role of collagen cross-linking","volume":"41","author":"Siegmund","year":"2008","journal-title":"J Biomech"},{"key":"10.1016\/j.bone.2013.02.004_bb0085","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/jbmr.1501","article-title":"Bone micromechanical properties are compromised during long-term alendronate therapy independently of mineralization","volume":"27","author":"Bala","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.02.004_bb0090","doi-asserted-by":"crossref","first-page":"e35047","DOI":"10.1371\/journal.pone.0035047","article-title":"Heterogeneous glycation of cancellous bone and its association with bone quality and fragility","volume":"7","author":"Karim","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2013.02.004_bb0095","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.bone.2006.12.056","article-title":"Effects of non-enzymatic glycation on cancellous bone fragility","volume":"40","author":"Tang","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.bone.2013.02.004_bb0100","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S8756-3282(00)00434-8","article-title":"Influence of nonenzymatic glycation on biomechanical properties of cortical bone","volume":"28","author":"Vashishth","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.bone.2013.02.004_bb0105","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00198-008-0725-9","article-title":"Spectroscopic markers of bone quality in alendronate-treated postmenopausal women","volume":"20","author":"Boskey","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2013.02.004_bb0110","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/jbmr.560","article-title":"Reduced cortical bone compositional heterogeneity with bisphosphonate treatment in postmenopausal women with intertrochanteric and subtrochanteric fractures","volume":"27","author":"Donnelly","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.02.004_bb0115","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.bone.2011.09.042","article-title":"Mechanical property and tissue mineral density differences among severely suppressed bone turnover (SSBT) patients, osteoporotic patients, and normal subjects","volume":"49","author":"Tjhia","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bone.2013.02.004_bb0120","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00198-008-0754-4","article-title":"Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate","volume":"20","author":"Tang","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2013.02.004_bb0125","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/8756-3282(93)90235-3","article-title":"Increased intracortical remodeling following fatigue damage","volume":"14","author":"Mori","year":"1993","journal-title":"Bone"},{"key":"10.1016\/j.bone.2013.02.004_bb0130","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s002230010036","article-title":"Bisphosphonate treatment suppresses not only stochastic remodeling but also the targeted repair of microdamage","volume":"69","author":"Li","year":"2001","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.bone.2013.02.004_bb0135","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.bone.2007.04.198","article-title":"Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis","volume":"41","author":"Stepan","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.bone.2013.02.004_bb0140","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1359\/jbmr.070609","article-title":"Microcrack frequency and bone remodeling in postmenopausal osteoporotic women on long-term bisphosphonates. A bone biopsy study","volume":"22","author":"Chapurlat","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.02.004_bb0145","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s00223-008-9131-8","article-title":"Alendronate reduces bone toughness of ribs without significantly increasing microdamage accumulation in dogs following 3years of daily treatment","volume":"82","author":"Allen","year":"2008","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.bone.2013.02.004_bb0150","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1001\/jama.296.24.2927","article-title":"Effects of continuing or stopping alendronate after 5years of treatment: the fracture intervention long-term extension (FLEX): a randomized trial","volume":"296","author":"Black","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2013.02.004_bb0155","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1002\/jbmr.1719","article-title":"Incidence of atypical nontraumatic diaphyseal fractures of the femur","volume":"27","author":"Dell","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.02.004_bb0160","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1056\/NEJMoa1010650","article-title":"Bisphosphonate use and atypical fractures of the femoral shaft","volume":"364","author":"Schilcher","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2013.02.004_bb0165","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bone.2012.02.632","article-title":"Clinical correlates of atypical femoral fracture","volume":"51","author":"Lo","year":"2012","journal-title":"Bone"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328213000677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328213000677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:38:12Z","timestamp":1757612292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328213000677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S8756328213000677"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2013.02.004","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proposed pathogenesis for atypical femoral fractures: Lessons from materials research","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2013.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}